Clinical study on Habb-e-Asgand in the management of Rheumatoid Arthritis

To Evaluate the therapeutic efficacy of Habb-e-Asgand in the management of Waja-ul-Mafasil(Rheumatoid Arthritis).A Randomized, Single blind, Standard Controlled Trial.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/01/039602

Enrollment

Registered

2022-01-20

Start date

Unknown

Completion date

Unknown

Last updated

2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M057- Rheumatoid arthritis with rheumatoid factor without organ or systems involvement

Interventions

Intervention1: Habb-e-Asgand (Pills): Ajwayin Desi(20g), Asgand(40g), Bidhara(40g), Bidhara(40g), Peepla Mool(20g), Pipal kalan(20g), Zanjabeel(40g), Satawar(40g), Musli siyah(20g) all are grounded to

Eligibility

Inclusion criteria

Inclusion criteria: 1 Clinically diagnosed /or serological evidence of Rheumatoid arthritis(Waja-ul-Mafasil). 2 Patients who have agreed to sign the informed consent, follow the protocol and willing to participate in clinical trial voluntarily.3 Mild to Moderate cases of Rheumatoid Arthritis.4 Have a diagnosis of Rheumatoid Arthritis (RA) as defined by American College of Rheumatology/ European League Against Rheumatism (ACR/EULAR)2010 Criteria for the Classification of RA.

Exclusion criteria

Exclusion criteria: 1. Uncontrolled Diabetes mellitus. 2. Hepatic or Renal insufficiency. 3. Other type of arthritis. 4. Pregnancy and lactation. 5. Any joint surgery in the previous 6 months 6. Patients with cardiovascular diseases. 7. Patients who refuse to give the written consent for the study. 8. Severe cases of Rheumatoid Arthritis

Design outcomes

Primary

Measure	Time frame
Relief in signs and symptoms of Rheumatoid arthritisTimepoint: 45 days	—

Secondary

Measure	Time frame
Haematological, Radiological and Biochemical assessmentTimepoint: 45 days	—

Countries

India

Contacts

Public ContactDr Zaffar Hussain

Regional Research Institute of Unani Medicine, Srinagar

hussainzaffar6@gmail.com7006021996

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026